There's bo reason they couldn't have a different LCC accumulating on the buy side. They lose brokerage, but split the holding across multiple companies. The buying Co would have no disclosure obligations, nor would Sabby after falling below 5% - although I didn't see a sub holder notice when they did.
Cardiocel Revenue and Company Growth, page-139
-
- There are more pages in this discussion • 211 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
0.000(0.00%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $14.05 | $14.05 | $14.00 | $10.45K | 747 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 663 | $13.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.99 | 400 | 1 |
View Market Depth
| Last trade - 10.18am 08/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |